Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Mar;51(3):525–534.

The enhancement of eosinophil function by lymphocyte supernatants.

R Sher, A Wadee, M Joffe
PMCID: PMC1536804  PMID: 6303654

Abstract

Supernatants obtained from non-stimulated lymphocytes, lymphocytes stimulated with phytohaemagglutinin and lymphocytes from patients with schistosomiasis that were stimulated with Schistosomiasis haematobium ova were shown to enhance a number of eosinophil functions. Eosinophil chemotaxis, phagocytosis, microbicidal activity, Nitro blue tetrazolium reduction, hexose monophosphate shunt activity and glycolysis were increased. Eosinophil iodination was not affected. Only those supernatants obtained from phytohaemagglutinin stimulated lymphocytes and lymphocytes from patients with schistosomiasis that were stimulated with S. haematobium ova showed eosinophil chemotactic activity. The active factor was found to be heat stable, and had no effect on cAMP and cGMP metabolism. The most likely mechanism of enhanced eosinophil function is through the increased activity of the hexose monophosphate shunt activity and glycolysis.

Full text

PDF
525

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anders E. M., Natvig J. B. Cell-mediated immunity to viruses measured by the indirect agarose technique of leukocyte migration inhibition. Cell Immunol. 1976 Dec;27(2):214–229. doi: 10.1016/0008-8749(76)90230-6. [DOI] [PubMed] [Google Scholar]
  2. Anderson R., Glover A., Rabson A. R. The effect of chemotactic factors and agents which influence neutrophil movement on anaerobic glycolysis and hexose monophosphate shunt activity. Immunology. 1978 Jul;35(1):141–149. [PMC free article] [PubMed] [Google Scholar]
  3. Arvilommi H., Räsänen L. Spontaneous lymphokine synthesis by human blood mononuclear cells. Nature. 1975 Sep 11;257(5522):144–146. doi: 10.1038/257144a0. [DOI] [PubMed] [Google Scholar]
  4. Basten A., Beeson P. B. Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med. 1970 Jun 1;131(6):1288–1305. doi: 10.1084/jem.131.6.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cline M. J., Hanifin J., Lehrer R. I. Phagocytosis by human eosinophils. Blood. 1968 Dec;32(6):922–934. [PubMed] [Google Scholar]
  6. Cline M. J., Melmon K. L., Davis W. C., Williams H. E. Mechanism of endotoxin interaction with human leucocytes. Br J Haematol. 1968 Dec;15(6):539–547. doi: 10.1111/j.1365-2141.1968.tb01576.x. [DOI] [PubMed] [Google Scholar]
  7. Colley D. G. Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin. J Immunol. 1973 May;110(5):1419–1423. [PubMed] [Google Scholar]
  8. DeChatelet L. R., Shirley P. S., McPhail L. C., Huntley C. C., Muss H. B., Bass D. A. Oxidative metabolism of the human eosinophil. Blood. 1977 Sep;50(3):525–535. [PubMed] [Google Scholar]
  9. Dumonde D. C., Wolstencroft R. A., Panayi G. S., Matthew M., Morley J., Howson W. T. "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature. 1969 Oct 4;224(5214):38–42. doi: 10.1038/224038a0. [DOI] [PubMed] [Google Scholar]
  10. Kazura J. W., Mahmoud A. A., Karb K. S., Warren K. S. The lymphokine eosinophil stimulation promoter and human schistosomiasis mansoni. J Infect Dis. 1975 Dec;132(6):702–706. doi: 10.1093/infdis/132.6.702. [DOI] [PubMed] [Google Scholar]
  11. Klebanoff S. J., Clark R. A. Iodination by human polymorphonuclear leukocytes: a re-evaluation. J Lab Clin Med. 1977 Mar;89(3):675–686. [PubMed] [Google Scholar]
  12. Kuntz M. M., Innes J. B., Weksler M. E. Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes. J Exp Med. 1976 May 1;143(5):1042–1054. doi: 10.1084/jem.143.5.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lehrer R. I. Functional aspects of a second mechanism of candidacidal activity by human neutrophils. J Clin Invest. 1972 Oct;51(10):2566–2572. doi: 10.1172/JCI107073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lehrer R. I. The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J Clin Invest. 1975 Feb;55(2):338–346. doi: 10.1172/JCI107937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McGarry M. P., Speirs R. S., Jenkins V. K., Trentin J. J. Lymphoid cell dependence of eosinophil response to antigen. J Exp Med. 1971 Sep 1;134(3 Pt 1):801–814. doi: 10.1084/jem.134.3.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Opelz G., Kiuchi M., Takasugi M., Terasaki P. I. Autologous stimulation of human lymphocyte subpopulation. J Exp Med. 1975 Nov 1;142(5):1327–1333. doi: 10.1084/jem.142.5.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pincus S. H., Klebanoff S. J. Quantitative leukocyte iodination. N Engl J Med. 1971 Apr 8;284(14):744–750. doi: 10.1056/NEJM197104082841402. [DOI] [PubMed] [Google Scholar]
  18. Quie P. G., White J. G., Holmes B., Good R. A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest. 1967 Apr;46(4):668–679. doi: 10.1172/JCI105568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ruscetti F. W., Cypess R. H., Chervenick P. A. Specific release of neutrophillic- and eosinophilic-stimulating factors from sensitized lymphocytes. Blood. 1976 May;47(5):757–765. [PubMed] [Google Scholar]
  20. Schriber R. A., Zucker-Fraklin D. Induction of blood eosinophilia by pulmonary embolization of antigen-coated particles: the relationship to cell-mediated immunity. J Immunol. 1975 Apr;114(4):1348–1353. [PubMed] [Google Scholar]
  21. Sher R., Anderson R., Rabson A. R., Koornhof H. J. Standardisation of the nitro-blue tetrazolium test and factors affecting its clinical application. S Afr Med J. 1974 Feb 9;48(6):209–212. [PubMed] [Google Scholar]
  22. Sher R., Glover A. Isolation of human eosinophils and their lymphocyte-like rosetting properties. Immunology. 1976 Sep;31(3):337–341. [PMC free article] [PubMed] [Google Scholar]
  23. WOOD H. G., KATZ J., LANDAU B. R. ESTIMATION OF PATHWAYS OF CARBOHYDRATE METABOLISM. Biochem Z. 1963;338:809–847. [PubMed] [Google Scholar]
  24. Wadee A. A., Anderson R., Sher R. In vitro effects of histamine on eosinophil migration. Int Arch Allergy Appl Immunol. 1980;63(3):322–329. doi: 10.1159/000232643. [DOI] [PubMed] [Google Scholar]
  25. Wadee A. A., Sher R., Rabson A. R. Production of a suppressor factor by human adherent cells treated with mycobacteria. J Immunol. 1980 Sep;125(3):1380–1386. [PubMed] [Google Scholar]
  26. Wadee A. A., Sher R. Staining of eosinophil granulocytes in chemotactic studies. J Immunol Methods. 1978;22(3-4):383–384. doi: 10.1016/0022-1759(78)90045-5. [DOI] [PubMed] [Google Scholar]
  27. Wadee A. A., Sher R. The effects of a soluble factor released by sensitized mononuclear cells incubated with S. haematobium ova on eosinophil migration. Immunology. 1980 Dec;41(4):989–995. [PMC free article] [PubMed] [Google Scholar]
  28. Walls R. S., Basten A., Leuchars E., Davies A. J. Mechanisms for eosinophilic and neutrophilic leucocytoses. Br Med J. 1971 Jul 17;3(5767):157–159. doi: 10.1136/bmj.3.5767.157. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES